טוען...
Neurological dysfunctions associated with altered BACE1-dependent Neuregulin-1 signaling
Inhibition of BACE1 is being pursued as a therapeutic target to treat patients suffering from Alzheimer’s disease because BACE1 is the sole β-secretase that generates β-amyloid peptide. Knowledge regarding other cellular functions of BACE1 is therefore critical for the safe use of BACE1 inhibitors i...
שמור ב:
| הוצא לאור ב: | J Neurochem |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4833723/ https://ncbi.nlm.nih.gov/pubmed/26465092 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jnc.13395 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|